RT Journal Article
SR Electronic
T1 Therapeutic Application of Dysprosium-165-FHMA in the Treatment of Rheumatoid Knee Effusions
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 18
OP 20
VO 14
IS 1
A1 English, Robert J.
A1 Zalutsky, Michael
A1 Venkatesan, Prasona
A1 Sledge, Clement B.
YR 1986
UL http://tech.snmjournals.org/content/14/1/18.abstract
AB Radiation synovectomy utilizing a variety of radionuclides has proven to be an effective technique in the treatment of rheumatoid arthritis. The recent introduction of the short-lived radionuclide, Dysprosium-165 (165Dy), as a replacement for the longer-lived radiocolloids has reduced nontarget dosimetry caused by leakage of the agent from the articular cavity. A review of the methods and status of radiation synovectomy, and the application of 165Dy-ferric hydroxide macroaggregates (FHMA) as an alternative therapeutic agent is described.